hypotension

The objective was to determine whether patients receiving vasopressors while concomitantly receiving enteral nutrients had more incidences of bowel ischemia and intolerance than those receiving enteral nutrition without vasopressor agents.

This paper summarizes the understood potential pathophysiology of postural tachycardia syndrome, associated GI and nutrition issues, general treatment of postural tachycardia syndrome, and strategies to assess and meet the unique needs of these patients.

We hypothesize that enteral nutrition delivery is not associated with worsening hemodynamic instability, as defined by an increase in vasopressor dose.